Who invested in Haihe Biopharma?
Haihe Biopharma's investors include Huagai Capital, Legend Capital, Warburg Pincus and Hill House Capital.

China · Series B startup
Funding summaryUpdated 26 Oct 2026
$317Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Haihe Biopharma's investors include Huagai Capital, Legend Capital, Warburg Pincus and Hill House Capital.
Haihe Biopharma has raised $317M across 2 rounds since 2019.
Haihe Biopharma's most recent round was a Series B of $171M in Jul 2020.
Its most recent round, $171M in Jul 2020, is also its largest on record.
Haihe Biopharma's first round on record, in Feb 2019, was backed by Huagai Capital.
Haihe Biopharma's latest named round is a Series B, in Jul 2020.
Haihe Biopharma is based in China.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.